Given its dual role in cancer progression, GABA and its receptors present a complex but promising therapeutic target. Inhibitors or agonists of GABA receptors are being explored for their potential to control tumor growth and spread. However, the therapeutic application of GABA in cancer treatment requires a deeper understanding of the specific mechanisms involved and the contextual factors that determine its effects.
